PHIA Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Koninklijke Philips N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €17.86 |
| 52 Week High | €22.87 |
| 52 Week Low | €11.61 |
| Beta | 0.85 |
| 1 Month Change | -2.00% |
| 3 Month Change | 16.74% |
| 1 Year Change | -21.88% |
| 3 Year Change | -53.76% |
| 5 Year Change | -47.83% |
| Change since IPO | 266.48% |
Recent News & Updates
Recent updates
Health Check: How Prudently Does Koninklijke Philips (AMS:PHIA) Use Debt?
Mar 30
Koninklijke Philips N.V. (AMS:PHIA) Shares Could Be 42% Below Their Intrinsic Value Estimate
Mar 03These 4 Measures Indicate That Koninklijke Philips (AMS:PHIA) Is Using Debt Extensively
Nov 21Is Now An Opportune Moment To Examine Koninklijke Philips N.V. (AMS:PHIA)?
Aug 26Here's Why Koninklijke Philips (AMS:PHIA) Has A Meaningful Debt Burden
Jul 27Why Koninklijke Philips N.V. (AMS:PHIA) Could Be Worth Watching
May 24Koninklijke Philips (AMS:PHIA) Is Due To Pay A Dividend Of €0.85
May 08Koninklijke Philips (AMS:PHIA) Will Pay A Dividend Of €0.85
Apr 24Koninklijke Philips' (AMS:PHIA) Dividend Will Be €0.85
Apr 10Here's Why Koninklijke Philips (AMS:PHIA) Can Manage Its Debt Responsibly
Mar 21Why Koninklijke Philips N.V. (AMS:PHIA) Could Be Worth Watching
Feb 14Is Koninklijke Philips (AMS:PHIA) Using Too Much Debt?
Dec 07Koninklijke Philips N.V. (AMS:PHIA) Shares Could Be 44% Below Their Intrinsic Value Estimate
Sep 18Koninklijke Philips (AMS:PHIA) Has A Pretty Healthy Balance Sheet
Aug 31Shareholder Returns
| PHIA | NL Medical Equipment | NL Market | |
|---|---|---|---|
| 7D | 1.2% | 0.5% | 1.4% |
| 1Y | -21.9% | -4.6% | 9.2% |
Return vs Industry: PHIA underperformed the Dutch Medical Equipment industry which returned -4.6% over the past year.
Return vs Market: PHIA underperformed the Dutch Market which returned 9.2% over the past year.
Price Volatility
| PHIA volatility | |
|---|---|
| PHIA Average Weekly Movement | 5.7% |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in NL Market | 8.3% |
| 10% least volatile stocks in NL Market | 2.3% |
Stable Share Price: PHIA is more volatile than 75% of Dutch stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: PHIA's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Dutch stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1891 | 77,233 | Roy Jakobs | https://www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.
Koninklijke Philips N.V. Fundamentals Summary
| PHIA fundamental statistics | |
|---|---|
| Market Cap | €16.45b |
| Earnings (TTM) | -€2.13b |
| Revenue (TTM) | €18.08b |
0.9x
P/S Ratio-7.7x
P/E RatioIs PHIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHIA income statement (TTM) | |
|---|---|
| Revenue | €18.08b |
| Cost of Revenue | €10.64b |
| Gross Profit | €7.44b |
| Other Expenses | €9.57b |
| Earnings | -€2.13b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Jul 24, 2023
| Earnings per share (EPS) | -2.32 |
| Gross Margin | 41.15% |
| Net Profit Margin | -11.79% |
| Debt/Equity Ratio | 61.7% |
How did PHIA perform over the long term?
See historical performance and comparison